Holen Sie sich die Stockscreener-App
14.79
0.89%
0.115
Fulgent Genetics Inc Aktie (FLGT) Neueste Nachrichten
Fulgent Genetics, Inc. Investigated by the Portnoy Law Firm - GlobeNewswire
Lowey Dannenberg, P.C. is Investigating Fulgent Genetics Inc. (NASDAQ: FLGT) for Potential Violations of the Federal Securities Laws and Encourages Investors to Contact the Firm - The Globe and Mail
Fulgent Genetics: A Major Market Misconception (NASDAQ:FLGT) - Seeking Alpha
Fulgent Genetics (FLGT) Earnings Transcript - AOL.com
Aug Sectors: Should I hold or sell Fulgent Genetics Inc now2026 Review & Precise Entry and Exit Recommendations - baoquankhu1.vn
Fulgent Genetics Hits New 52-Week Low at $14.01 Amid Declining Performance - Markets Mojo
Fulgent Genetics (NASDAQ:FLGT) Stock Rating Lowered by Wall Street Zen - MarketBeat
Technical Analysis: Is Fulgent Genetics Inc a top pick in the sectorQuarterly Earnings Report & AI Powered Trade Plan Recommendations - baoquankhu1.vn
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc.FLGT - PR Newswire
Fulgent Genetics, Inc. (NASDAQ:FLGT) Given Average Rating of "Hold" by Brokerages - MarketBeat
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc.FLGT - FinancialContent
FLGT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Fulgent Genetics (FLGT) CSO has shares withheld to cover RSU taxes - Stock Titan
Fulgent Genetics (NASDAQ: FLGT) CEO has shares withheld for taxes - Stock Titan
Fulgent Genetics (FLGT) Is Down 33.4% After 2025 Results And Oncology-Focused ExpansionWhat's Changed - Yahoo Finance
Fulgent Genetics, Inc. Shareholders Are Encouraged to Reach - GlobeNewswire
UBS Adjusts Fulgent Genetics Price Target to $22 From $35, Maintains Buy Rating - marketscreener.com
Fulgent Reports Fourth Quarter and Full Year 2025 Financial Results - marketscreener.com
Assessing Fulgent Genetics (FLGT) Valuation After Earnings Outperformance And AI Oncology Pipeline Progress - simplywall.st
A Look At Fulgent Genetics (FLGT) Valuation After 2025 Results And 2026 Revenue Guidance - Yahoo Finance
Fulgent Genetics (NASDAQ:FLGT) Releases Quarterly Earnings Results, Beats Expectations By $0.14 EPS - MarketBeat
Fulgent Genetics (FLGT) Loss Widening In Q4 2025 Tests Bullish Growth Narratives - simplywall.st
Fulgent Q4 2025 slides: EPS beats, but customer loss drives stock plunge - Investing.com Australia
Fulgent Genetics (FLGT) Reports Strong Q4 Revenue Growth - GuruFocus
Fulgent Genetics (NASDAQ:FLGT) Issues FY 2026 Earnings Guidance - MarketBeat
Fulgent Genetics Inc (FLGT) Q4 2025 Earnings Call Highlights: Na - GuruFocus
Fulgent Genetics Q4 Earnings Call Highlights - MarketBeat
Fulgent Genetics (FLGT) Reports Strong Q4 Earnings Despite Reven - GuruFocus
Earnings call transcript: Fulgent Genetics Q4 2025 beats EPS estimates, stock tumbles - Investing.com
Fulgent Genetics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Fulgent Genetics earnings beat by $0.22, revenue fell short of estimates - Investing.com Canada
Fulgent Genetics, Inc. (FLGT) Q4 Earnings Top Estimates - Yahoo Finance
Fulgent Genetics Posts 2025 Results and 2026 Outlook - TipRanks
Fulgent Genetics (FLGT) Reports Q4 Revenue Below Expectations - GuruFocus
FLGT Projects FY26 Revenue and Financial Outlook - GuruFocus
Fulgent Genetics Q4 Non-GAAP Net Income, Revenue Rise; 2026 Guidance Set -- Shares Down Pre-Bell - marketscreener.com
(FLGT) Fulgent Genetics Expects 2026 Revenue About $350M, vs. FactSet Est of $356.3M - marketscreener.com
(FLGT) Fulgent Expects 2026 Adjusted Loss About $1.45 a Share, vs. FactSet Est of $0.32 Loss - marketscreener.com
FULGENT GENETICS ($FLGT) Releases Q4 2025 Earnings - Quiver Quantitative
Earnings Flash (FLGT) Fulgent Genetics Posts Q4 Revenue $83.3M, vs. FactSet Est of $85.4M - marketscreener.com
Earnings Flash (FLGT) Fulgent Genetics Posts Q4 Adjusted EPS $0.16, vs. FactSet Est of $0.03 - marketscreener.com
Fulgent Genetics, Inc. SEC 10-K Report - TradingView
Fulgent Genetics Q4 revenue misses; forecasts about $350 mln in 2026 revenue - TradingView
Fulgent Genetics Q4 Earnings Assessment - Benzinga
BRIEF-Fulgent Genetics Q4 Revenue USD 83.336 Million - TradingView
Earnings Preview: Fulgent Genetics - Benzinga
Fulgent Genetics and Azenta Compared as Investments - National Today
Fulgent Genetics (FLGT) CEO receives stock awards and tax share withholding - Stock Titan
Fulgent Genetics (FLGT) COO receives stock awards and tax withholdings - Stock Titan
Fulgent Genetics (NASDAQ: FLGT) CFO gets equity awards, covers taxes - Stock Titan
ETF Watch: How liquid is Fulgent Genetics Inc stockQuarterly Market Review & Technical Entry and Exit Alerts - baoquankhu1.vn
Price-Driven Insight from (FLGT) for Rule-Based Strategy - Stock Traders Daily
Aug Wrap: Is Fulgent Genetics Inc a top pick in the sectorJuly 2025 Sentiment & Technical Pattern Based Buy Signals - baoquankhu1.vn
Highs Report: Will DALN benefit from rate cutsQuarterly Risk Review & Stepwise Trade Execution Plans - baoquankhu1.vn
What are Fulgent Genetics Inc.’s technical support levels2025 Technical Patterns & Smart Money Movement Tracker - mfd.ru
Fulgent Genetics (FLGT) Projected to Post Earnings on Friday - MarketBeat
RSI Check: What is the long term forecast for Fulgent Genetics Inc stock2025 Market Outlook & Growth-Oriented Investment Plans - baoquankhu1.vn
Is Fulgent Genetics Inc. (7F0) stock resilient in recession scenariosRecession Risk & Fast Exit Strategy with Risk Control - mfd.ru
1.11%
0.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):